en Experimental Neurobiology

Cited by CrossRef (26)

  1. Joel E. Beevers, Tara M. Caffrey, Richard Wade-Martins. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease. 2013;41:1503
    https://doi.org/10.1042/BST20130194
  2. Eric S. Luth, Irina G. Stavrovskaya, Tim Bartels, Bruce S. Kristal, Dennis J. Selkoe. Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction. Journal of Biological Chemistry 2014;289:21490
    https://doi.org/10.1074/jbc.M113.545749
  3. Mohammad Rafi Khezri, Ayda Esmaeili, Morteza Ghasemnejad-Berenji. Role of Bmal1 and Gut Microbiota in Alzheimer’s Disease and Parkinson’s Disease Pathophysiology: The Probable Effect of Melatonin on Their Association. ACS Chem. Neurosci. 2023;14:3883
    https://doi.org/10.1021/acschemneuro.3c00418
  4. Chaoxiu Ren, Xiangang Hu, Qixing Zhou. Graphene Oxide Quantum Dots Reduce Oxidative Stress and Inhibit Neurotoxicity In Vitro and In Vivo through Catalase‐Like Activity and Metabolic Regulation. Advanced Science 2018;5
    https://doi.org/10.1002/advs.201700595
  5. Ji Ae Lee, Hyo Jin Son, Ji Won Choi, Jinwoo Kim, Se Hee Han, Nari Shin, Ji Hyun Kim, Soo Jeong Kim, Jun Young Heo, Dong Jin Kim, Ki Duk Park, Onyou Hwang. Activation of the Nrf2 signaling pathway and neuroprotection of nigral dopaminergic neurons by a novel synthetic compound KMS99220. Neurochemistry International 2018;112:96
    https://doi.org/10.1016/j.neuint.2017.11.006
  6. Alexa Klettner, Andreas Tholey, Alena Wiegandt, Elisabeth Richert, Bernhard Nölle, Günther Deuschl, Johann Roider, Susanne A. Schneider. Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker. Movement Disorders 2017;32:459
    https://doi.org/10.1002/mds.26863
  7. Han-Joon Kim, Beom S. Jeon. Hypothesis: Somatic Mosaicism and Parkinson Disease. Exp Neurobiol 2014;23:271
    https://doi.org/10.5607/en.2014.23.4.271
  8. Huda Saleh, Ayeh Saleh, Hailan Yao, Jie Cui, Yong Shen, Rena Li. Mini review: linkage between α-Synuclein protein and cognition. Transl Neurodegener 2015;4
    https://doi.org/10.1186/s40035-015-0026-0
  9. Michael Tolmasov, Ruth Djaldetti, Nirit Lev, Yossi Gilgun-Sherki. Pathological and clinical aspects of alpha/beta synuclein in Parkinson’s disease and related disorders. Expert Review of Neurotherapeutics 2016;16:505
    https://doi.org/10.1586/14737175.2016.1164600
  10. Xinran Cui, Chen Xu, Liyuan Zhang, Yadong Wang. Identification of Parkinson’s Disease-Causing Genes via Omics Data. Front. Genet. 2021;12
    https://doi.org/10.3389/fgene.2021.712164
  11. Roshan Kumar, Deepak K. Jangir, Garima Verma, Shashi Shekhar, Pranita Hanpude, Sanjay Kumar, Raniki Kumari, Nirpendra Singh, Neel Sarovar Bhavesh, Nihar Ranjan Jana, Tushar Kanti Maiti. S-nitrosylation of UCHL1 induces its structural instability and promotes α-synuclein aggregation. Sci Rep 2017;7
    https://doi.org/10.1038/srep44558
  12. Agata Mulak. Brain-gut-microbiota axis in Parkinson's disease. WJG 2015;21:10609
    https://doi.org/10.3748/wjg.v21.i37.10609
  13. Babita Singh, Shivani Pandey, Mohammad Rumman, Abbas Ali Mahdi. Neuroprotective effects of Bacopa monnieri in Parkinson’s disease model. Metab Brain Dis 2020;35:517
    https://doi.org/10.1007/s11011-019-00526-w
  14. Leszek Szablewski. Comprehensive Gut Microbiota. 2020.
    https://doi.org/10.1016/B978-0-12-819265-8.00065-6
  15. Bok‐Seok Kim, Taeik Jang, Sung‐Eun Yoo, Jae Moon Lee, Eunhee Kim. Fas‐associated factor 1 induces the accumulation of α‐synuclein through autophagic suppression in dopaminergic neurons. The FASEB Journal 2021;35
    https://doi.org/10.1096/fj.202001371RR
  16. Iva Stojkovska, Brandon M Wagner, Brad E Morrison. Parkinson’s disease and enhanced inflammatory response. Exp Biol Med (Maywood) 2015;240:1387
    https://doi.org/10.1177/1535370215576313
  17. Young-Cho Kim, Adam Miller, Livia C. R. F. Lins, Sang-Woo Han, Megan S. Keiser, Ryan L. Boudreau, Beverly L. Davidson, Nandakumar S. Narayanan. RNA Interference of Human α-Synuclein in Mouse. Front. Neurol. 2017;8
    https://doi.org/10.3389/fneur.2017.00013
  18. Zili Luo, Katelin E. Ahlers-Dannen, Mackenzie M. Spicer, Jianqi Yang, Stephanie Alberico, Hanna E. Stevens, Nandakumar S. Narayanan, Rory A. Fisher. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice. 2019;4
    https://doi.org/10.1172/jci.insight.126769
  19. Katelin E. Ahlers-Dannen, Mackenzie M. Spicer, Rory A. Fisher. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson’s Disease. Mol Pharmacol 2020;98:730
    https://doi.org/10.1124/mol.119.118836
  20. Yuhang Liu, Juelu Wang, Ging-Yuek Robin Hsiung, Weihong Song. Trehalose Inhibits Aβ Generation and Plaque Formation in Alzheimer’s Disease. Mol Neurobiol 2020;57:3150
    https://doi.org/10.1007/s12035-020-01942-1
  21. Carlos Fernández-Moriano, Elena González-Burgos, M. Pilar Gómez-Serranillos. Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases. Oxidative Medicine and Cellular Longevity 2015;2015:1
    https://doi.org/10.1155/2015/408927
  22. Natasa Kustrimovic, Franca Marino, Marco Cosentino. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease. CMC 2019;26:3719
    https://doi.org/10.2174/0929867325666181009161048
  23. S. García, G. Chavira-Hernández, M.P. Gallegos-Arreola, L. Dávila-Maldonado, F. García Martínez, L.A. Montes Almanza, C. Palma-Flores, P. Mondragón-Terán, S.L. Alcaraz Estrada, L. B. López-Hernández. The rs3857059 variant of the SNCA gene is associated with Parkinson’s disease in Mexican Mestizos. Arq. Neuro-Psiquiatr. 2016;74:445
    https://doi.org/10.1590/0004-282x20160061
  24. Ali M. Al-Radaideh, Eman M. Rababah. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review. Clinical Imaging 2016;40:987
    https://doi.org/10.1016/j.clinimag.2016.05.006
  25. Ilse S. Pienaar, Joanna L. Elson, Claudia Racca, Glyn Nelson, Douglass M. Turnbull, Christopher M. Morris. Mitochondrial Abnormality Associates with Type-Specific Neuronal Loss and Cell Morphology Changes in the Pedunculopontine Nucleus in Parkinson Disease. The American Journal of Pathology 2013;183:1826
    https://doi.org/10.1016/j.ajpath.2013.09.002
  26. Brennon Luster, Erica Petersen, Edgar Garcia-Rill. Waking and the Reticular Activating System in Health and Disease. 2013.
    https://doi.org/10.1016/B978-0-12-801385-4.00012-4